4
Views
8
CrossRef citations to date
0
Altmetric
Original Article

A Phase II Study of Merbarone in Patients with Adenocarcinoma of the Pancreas

, , , , &
Pages 667-669 | Published online: 11 Jun 2009

References

  • Brewer A, Minatelli J, Plowman J, et al. 5-(N-Phenylcarbox-amido)-2-thiobarbituric acid (NSC 336628); A novel antitumor agent. Biochem Pharmacol 1985; 34: 2047–2050
  • Glover A, Chun H, Kleinman L, et al. Merbarone: An antitumor agent entering clinical trials. Invest New Drugs 1987; 5: 137–143
  • Dimaggio J, Warrell R, Muindi J, et al. Phase I clinical and pharmacological study of merbarone. Cancer Res 1990; 50: 1151–1155
  • Carter S, Comis R. Integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocar-cinoma. Cancer Treat Rev 1975; 2: 193–214
  • Moertel C. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol 1976; 5: 777–793
  • Crooke S, Bradner W. Mitomycin C: A review. Cancer Treat Rev 1976; 3: 121–139
  • Kemmenoe B, Malspeis L. Distribution of [2-−14C]-merbarone in mice by autoradiography of whole body cryosections (abstract). Proc Am Assoc Cancer Res 1986; 27: 402
  • Clinical Brochure for Merbarone. Division of Cancer Treatment, National Cancer Institute, Bethesda, MD October, 1985

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.